tbuckley/cabot-search huggingface dataset:
THE ST. PAUL MEETING AND YELLOWSTONE PARK.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cancer Treatment Symposia (Volume 1,1984): “The Interdisciplinary Program for Radiation Oncology Research” Available
Journal: JNCI Journal of the National Cancer Institute (1984)

Cancer Treatment Symposia (Volume 1,1984): “The Interdisciplinary Program for Radiation Oncology Research” Available Get access JNCI: Journal of the National Cancer Institute, Volume 72, Issue 4, April 1984, Page 965, https://doi.org/10.1093/jnci/72.4.965 Published: 01 April 1984
Broadening horizons of allergy
Authors: P. M. Gottlieb
Journal: JAMA (1965)

The lessons of history, if thoughtfully perused, may cast some illumination on the pathways of the future. The development of a body of knowledge and of clinical and experimental techniques to the point of constituting a new scientific discipline and an independent medical specialty requires myriads of observations, experiments, and studies. These constitute a tribute to the ingenuity, insight, perseverance, and dedication of a host of clinicians and investigators of past generations and of the current scientific scene. Allergy, like most medical specialties, was presaged by scattered and unorganized clinical observations over centuries. Unlike the other specialties, however, it is the first to be distinguished by attention to a modality of disease causation—the phenomenon of hypersensitivity—rather than by delineation in terms of an organ system, age group, or therapeutic approach. The gradual conceptualization of the possibility that hypersensitiveness to otherwise innocuous substances may produce disease in predisposed individuals required a
Estrogen withdrawal syndrome
Authors: S. S. Yen
Journal: JAMA (1986)

Nearly a decade ago, I proposed the term "estrogen withdrawal syndrome" to emphasize the importance of health and well-being and socioeconomic impacts during and after the transition of menopause.<sup>1</sup>While menopause is a component of the complex process of aging, a well-recognized set of functional changes is attributable to estrogen withdrawal, such as hot flushes and accelerated bone loss. Women with gonadal dysgenesis, who have never had normal levels of endogenous estrogen, do not experience flushes even at an advanced age. However, when estrogen is administered for several months and then treatment is discontinued, these women experience classic menopausal flushes for the first time.<sup>1</sup>This observation suggests that menopausal flushes are a manifestation of a classic withdrawal syndrome, mediated through functional changes of estrogen-sensitive neurons within the brain, which are linked to thermoregulation.<sup>2,3</sup> The long-term and more serious consequence of estrogen deficiency is the accelerated bone loss,
Erratum: Resting-state connectivity biomarkers define neurophysiological subtypes of depression
Authors: Andrew T Drysdale, Logan Grosenick, Jonathan Downar, Katharine Dunlop, Farrokh Mansouri, Yue Meng, Robert N Fetcho, Benjamin Zebley, Desmond J Oathes, Amit Etkin, Alan F Schatzberg, Keith Sudheimer, Jennifer Keller, Helen S Mayberg, Faith M Gunning, George S Alexopoulos, Michael D Fox, Alvaro Pascual-Leone, Henning U Voss, BJ Casey, Marc J Dubin, Conor Liston
Journal: Nature Medicine (2017)
Suppression of Menstruation
Authors: Lee Shropshire
Journal: JAMA (1967)

THE PURPOSE of this report is to outline a safe and efficient method of suppressing menstruation as a hygienic measure in the care of mentally retarded patients. In hospitals for the mentally retarded, menstruation can give rise to difficult problems, particularly in the care of severely or profoundly retarded patients. There are those who will not wear any type of sanitary protection, those who misuse soiled napkins and tampons, and those with unusually heavy flow. With the advent of the newer 19-nor-progestogens, complete suppression of ovulation and menstruation by medical means became practical and safe. In his work on endometriosis, Kistner<sup>1-5</sup>has proven that a state of pseudopregnancy can be maintained for long periods without deleterious effects. The safety of these drugs has also been well substantiated by other investigators.<sup>6,7</sup> <h3>Program</h3> A program of menstrual suppression was started at this hospital in August 1963, using norethynodrel with mestranol
Autopsy
Journal: JAMA (1987)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Thyroiditis
Authors: Elizabeth N. Pearce, Alan P. Farwell, Lewis E. Braverman
Journal: New England Journal of Medicine (2003)

This article summarizes the current understanding of the mechanisms of destruction in autoimmune thyroid disease. The authors explain the approach to the diagnosis and treatment of the most common types of thyroiditis, including Hashimoto's thyroiditis, painless postpartum thyroiditis, and painless sporadic thyroiditis. Thyroid dysfunction can also develop from treatment with medications such as amiodarone, lithium, interferon alfa, and interleukin-2.
Regional variation in the incidence of hip fracture. US white women aged 65 years and older
Authors: S. J. Jacobsen
Journal: JAMA (1990)

FRACTURE of the hip is a major cause of morbidity and mortality in persons 65 years of age and older. Incidence rates for hip fracture are known to vary by both sex and race.<sup>1-4</sup>There is also marked variability in hip fracture incidence by geographic region, with the highest rates found in Scandinavia, followed by the United States, Western Europe, Asia, and Africa.<sup>5,6</sup> Within the United States, relatively little is known about the geographic pattern of hip fracture. Most studies have described the incidence of hip fracture for the country as a whole,<sup>2,3</sup>for limited geographic regions,<sup>4,7,8</sup>or by broadly defined Census divisions.<sup>9</sup>This study examines the geographic distribution of hip fracture incidence in the United States at the county level. To this end, data are obtained from the Health Care Financing Administration (HCFA) and the Department of Veterans Affairs (VA) that identify all hospital
Identifying Patients at Risk for Thromboembolism
Authors: Natalio Cristal
Journal: JAMA (1976)

Fibrinogen labeled with iodine 125 was used to detect deep vein thrombosis (DVT) in 35 patients during their course and convalescence from acute myocardial infarction. Clinical status was assessed and scored with the use of a modified coronary prognostic index.<sup>1</sup>According to the prognostic scores, patients were allocated to one of two groups. Of 27 patients in good clinical condition, DVT developed in only one patient, whereas thromboembolic complications occurred in seven of eight patients who were severely ill—a highly significant difference. Prophylactic anticoagulation is advisable in patients at risk. (<i>JAMA</i>236:2755-2757, 1976)
Cholesterol Screening of Children
Authors: Gianfranco Domenighetti
Journal: JAMA (1991)

<h3>To the Editor.—</h3> To the "cholesterol saga" presented in the December 19, 1990, issue ofThe Journal, we would like to add a "cost-misdeedness" analysis. The wave of enthusiasm for the beneficial effects of lowering blood cholesterol concentrations by pharmacological intervention in asymptomatic persons who are free of a history of coronary heart disease requires such an analysis. High plasma cholesterol levels are widely recognized as a major risk factor for heart disease and related mortality,<sup>1,2</sup>but no evidence has yet been found that reducing cholesterol levels by drugs and diet can, in primary prevention trials, reduce total mortality.<sup>3</sup> Since total mortality and long life expectancy are still considered nontrivial end points and since cost containment is a major public policy concern, the worrisome results of the three largest randomized primary prevention drug trials<sup>4-8</sup>seem to ask for time for us to reflect before we introduce interventions. A
Editorial: The time in which we live
Authors: H. H. Hussey
Journal: JAMA (1975)

Fifty years ago, a 15-year-old boy, having finished his homework for that school day, performed his usual evening exercise in the best tradition of the boys' stories he had read. With his lively little mongrel, he walked about a mile to a park gate, entered, and soon found a brick path on which he ran as hard as he could for the mile and a half that brought him to another gate. By then, the moon had risen to enhance the light of the gas lampposts on his ten-block walk back to the row house that was typical of his middle-class neighborhood. All the way, the dark had been a little scary; but not the passersby he had encountered. There was no reason to fear attack. Robert A. Heinlein, in one of his science fiction stories, wrote about changes that had occurred approximately a generation later.<sup>1</sup> Law-abiding people hardly
Highlights
Journal: JAMA (2018)

Intensive care unit nurses are exposed to occupational stress in the form of time pressure, high workloads, interpersonal confl icts, and moral and spiritual distress.El Khamali and colleagues for the SISTRESSREA Study Group enrolled 198 intensive care unit nurses in a randomized clinical trial and found that a multimodal intervention with education, roleplay, and debriefi ng resulted in a lower prevalence of job strain.In an Editorial, Seaman and colleagues suggest that reducing job-related stress may increase the productivity of nurses and improve their quality of care.
ETHER ANÆSTHESIA.
Authors: J. D. RUSHMORE
Journal: JAMA (1992)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
HETEROTOPIC INTESTINAL MUCOSA AS A POSSIBLE FACTOR IN THE GENESIS OF GASTRIC ULCER
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
“Months, Not Years”: Impact of Clinical Discussions of Advanced Cancer Life-Expectancy on Patient Illness Understanding.
Authors: Andrew S. Epstein, Holly Gwen Prigerson, Leonard Saltz, Eileen Mary O'Reilly, Manish A. Shah, Paul K Maciejewski
Journal: Journal of Clinical Oncology (2015)

9549 Background: Patients’ understanding of their illness often guides best practice, and this is no less true at the end of life. Data showing the influence of patients’ acknowledgment of prognostic discussions on the accuracy of patients’ illness understanding could inform the debate regarding how to engage in these difficult discussions. Methods: To evaluate the effects of recent and past oncologist-patient discussions about prognosis/life-expectancy (P/LE) on changes in advanced cancer patents’ illness understanding (acknowledgement of their illness as 1. terminal; 2. incurable; 3. advance staged; and 4. associated with an estimated life-expectancy in months, not years), 208 patients (with advanced lung or upper gastrointestinal cancers that progressed on 1 chemotherapy regimen, or advanced colorectal cancers that progressed on 2) from Coping with Cancer II, a prospective observational cohort study, were interviewed before and after a visit with their oncologists who discussed scan results regarding potential additional progression. Results: Median time between pre- and post-scan interviews was 38 days. Controlling for potential confounds (i.e., patients’ race) and adjusting for patients’ pre-scan illness understanding, patients who acknowledged ever having discussions of P/LE with their oncologists were more likely to recognize that their disease was incurable (Adjusted Odds Ratio [AOR] = 2.97, p = 0.009) than those who did not. Compared to patients who denied ever having a discussion of P/LE, those who reported having both recent and past discussions of P/LE were more likely to recognize that their disease was at an advanced stage (AOR = 4.88, p = 0.012), and those who reported having only recent discussions, or both recent and past discussions, of P/LE were more likely to estimate their life-expectancy in terms of months as opposed to years (AOR = 10.1, p = 0.050, and AOR = 17.5, p = 0.006, respectively). Conclusions: Advanced cancer patients who acknowledge having discussions of P/LE with their oncologists have a better understanding of the terminal nature of their illnesses as compared to those who do not, and thus may be better prepared to make informed end-of-life care decisions.
Psoriasis and Risk of Myocardial Infarction
Authors: Mario Malerba, Paolo Gisondi, Alessandro Radaeli, Giampiero Girolomoni
Journal: JAMA (2007)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The management of ureteral stones
Authors: M. H. Nourse
Journal: JAMA (1966)

The earliest specimen of vesical calculus was discovered by Prof Elliot Smith<sup>1</sup>in the grave of a predynastic and prehistoric Egyptian boy of 15 or 16. He considered it to have been several centuries prior to Mena, the first king of Egypt, who reigned somewhere between the years 4800 and 4500 BC. The calculus must, therefore, be about 7,000 years old at the present time. It rests in the Hunterian Museum, Royal College of Surgeons, England. Hippocrates<sup>2</sup>(460-370 BC) recognized both renal and vesical calculus and described symptoms of each. He was a daring surgeon but he considered wounds of the bladder to be mortal and forbade his followers to operate for a stone in the bladder. You may recall that he makes mention of this in his famous oath, "Neither will I cut them that have stone, but will leave this operation to those who are accustomed
THE MEMORIAL INSTITUTE FOR INFECTIOUS DISEASES.
Journal: JAMA (1902)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Preciseness and specificity for medical records
Authors: B. L. Gordon
Journal: JAMA (1966)

Effective presentations of medical data are essential in the furtherance of modern medicine: for the continuing study and treatment of individual patients; as source material for statistical analysis of diseases and conditions; to reflect the contributions of preventive medicine, definitive treatment, and rehabilitation; to reveal the changing modes of diagnosis and treatment as influenced by the developments of clinical and fundamental research; for references in medical education and journalism; and in compliance with regulations of the US government and private agencies for information pertaining to claims for illnesses, injuries, and disability. The applications of computer technology in the handling of scientific data strike the imagination and emphasize the needs for thoughtful, authoritative, functional, and timely documentation. Accordingly, chiefs of hospital services, administrators, and accreditation boards strongly urge the perfection of medical records, first, for professional purposes and, second, to reflect the skills and excellence of diagnosis and the benefits of
CALCIUM REQUIREMENT OF HUMAN FETUS
Journal: JAMA (1922)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal